RxDoctor Payments Data

Elizabeth Watson, PA

Physician Assistant · Grand Rapids, MINPI 1518297597

Payments from drug & device makers

$2,666in general payments, 2019–2025

Across 46 payments — averaging $57.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$956
  • Novartis$375
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$318
  • Amgen$272
  • Boehringer Ingelheim$257
  • Johnson & Johnson$150
  • plus $337 from 6 others

What the payments were for

  • Food & beverage$2,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,666 in reported general payments places this provider in the 85th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$15,045
Medicare patients
101
Services billed
157

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$45,684
JardianceEmpagliflozin25$16,150
FarxigaDapagliflozin Propanediol22$15,840
EntrestoSacubitril/Valsartan13$10,860
Metoprolol Succinate46$768
Amiodarone Hcl20$726
Spironolactone50$482
Isosorbide Mononitrate ErIsosorbide Mononitrate18$357
Torsemide26$348
Atorvastatin Calcium26$313
Carvedilol27$302
Amlodipine Besylate20$218
Losartan Potassium21$181
Furosemide33$164
Lisinopril13$114

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$84$45,68456 claims
Boehringer IngelheimJardiance$257$16,15025 claims
AstraZenecaFarxiga$137$15,84022 claims
NovartisEntresto$375$10,86013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →